Michael E. Callender

539 total citations
9 papers, 381 citations indexed

About

Michael E. Callender is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Michael E. Callender has authored 9 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 5 papers in Hepatology and 2 papers in Surgery. Recurrent topics in Michael E. Callender's work include Liver Disease and Transplantation (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Diseases and Immunity (3 papers). Michael E. Callender is often cited by papers focused on Liver Disease and Transplantation (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Diseases and Immunity (3 papers). Michael E. Callender collaborates with scholars based in United Kingdom, Ireland and United States. Michael E. Callender's co-authors include William Dickey, S A McMillan, Ian Young, Dorothy McMaster, Neil McDougall, Tom G. Trouton, Elisabeth R. Trimble, Jane McEneny, Stephen O’Neill and Michael A. Heneghan and has published in prestigious journals such as Free Radical Biology and Medicine, Clinical Endocrinology and Liver Transplantation.

In The Last Decade

Michael E. Callender

9 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Callender United Kingdom 8 137 136 114 87 75 9 381
Michihiko Shibata Japan 10 129 0.9× 251 1.8× 92 0.8× 35 0.4× 30 0.4× 62 520
Claus Niederau Germany 10 80 0.6× 98 0.7× 118 1.0× 77 0.9× 6 0.1× 18 358
Stephan Jain United Kingdom 10 156 1.1× 160 1.2× 147 1.3× 89 1.0× 13 0.2× 12 449
Hubert Mörk Germany 15 166 1.2× 197 1.4× 214 1.9× 218 2.5× 55 0.7× 23 743
Lisandro Pereyra Argentina 10 36 0.3× 115 0.8× 128 1.1× 21 0.2× 62 0.8× 34 383
M J Farahvash Iran 8 334 2.4× 947 7.0× 250 2.2× 50 0.6× 47 0.6× 18 1.2k
Yuichi Masuda Japan 15 106 0.8× 71 0.5× 241 2.1× 25 0.3× 11 0.1× 44 626
Fujito Kageyama Japan 7 204 1.5× 201 1.5× 107 0.9× 17 0.2× 8 0.1× 23 362
Makau Lee United States 12 42 0.3× 47 0.3× 221 1.9× 16 0.2× 48 0.6× 21 497
Denise Kalmaz United States 10 79 0.6× 87 0.6× 179 1.6× 26 0.3× 43 0.6× 21 621

Countries citing papers authored by Michael E. Callender

Since Specialization
Citations

This map shows the geographic impact of Michael E. Callender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Callender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Callender more than expected).

Fields of papers citing papers by Michael E. Callender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Callender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Callender. The network helps show where Michael E. Callender may publish in the future.

Co-authorship network of co-authors of Michael E. Callender

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Callender. A scholar is included among the top collaborators of Michael E. Callender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Callender. Michael E. Callender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
O’Neill, Stephen, Mark E. O’Donnell, David R. McCance, et al.. (2014). Endothelial function, antioxidant status and vascular compliance in newly diagnosed HFE C282Y homozygotes. Advances in Medical Sciences. 59(1). 28–33. 3 indexed citations
2.
O’Neill, Stephen, Mark E. O’Donnell, David R. McCance, et al.. (2013). Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis. Liver International. 33(8). 1166–1174. 42 indexed citations
3.
Hunter, Michael, et al.. (2011). Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis.. PubMed. 80(1). 15–8. 8 indexed citations
4.
McCance, David R., et al.. (2010). Primary biliary cirrhosis is associated with oxidative stress and endothelial dysfunction but not increased cardiovascular risk. Hepatology Research. 40(11). 1098–1106. 24 indexed citations
5.
Austin, Mark, Neil McDougall, Julia Wendon, et al.. (2008). Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver Transplantation. 14(3). 287–291. 63 indexed citations
6.
Dickey, William, S A McMillan, & Michael E. Callender. (1997). High Prevalence of Celiac Sprue among Patients with Primary Biliary Cirrhosis. Journal of Clinical Gastroenterology. 25(1). 328–329. 80 indexed citations
7.
Hunter, Steven, William H. Daughaday, Michael E. Callender, et al.. (1994). A case of hepatoma associated with hypoglycaemia and overproduction of IGF‐II (E‐21): beneficial effects of treatment with growth hormone and intrahepatic adriamycin. Clinical Endocrinology. 41(3). 397–401. 32 indexed citations
8.
Young, Ian, et al.. (1994). Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radical Biology and Medicine. 16(3). 393–397. 97 indexed citations
9.
Dinsmore, W W, et al.. (1985). Zinc Absorption in Alcoholics Using Zinc-65. Digestion. 32(4). 238–242. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026